The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: Is an additional pre-operative injection effective?

Journal of Bone and Joint Surgery - Series B

Volumn 94 B, Issue 7, 2012, Pages 932-936

  Lin, P C ^a   Hsu, C H ^a   Huang, C C ^a   Chen, W S ^a   Wang, J W ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTICLE; CLIMBING; COHORT ANALYSIS; CONTROLLED STUDY; EXPECTATION; FEMALE; GENDER; HIP ARTHROPLASTY; HUMAN; JOINT MOBILITY; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; PATIENT SATISFACTION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SHORT FORM 12; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBINS; HEMOSTASIS, SURGICAL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TRANEXAMIC ACID;

EID: 84863437035     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.94B7.28386     Document Type: Article

References (38)

1. Callaghan JJ, O'Rourke MR, Liu SS. Blood management: issues and options. J Arthroplasty 2005;20(Suppl 2):51-54. (Pubitemid 41327560)
2. Keating EM, Meding JB, Faris PM, Ritter MA. Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 1998;357:50-59. (Pubitemid 29022432)
3. Mylod AG Jr, France MP, Muser DE, Parsons JR. Perioperative blood loss associated with total knee arthroplasty: a comparison of procedures performed with and without cementing. J Bone Joint Surg [Am] 1990;72-A:1010-1012. (Pubitemid 20279630)
4. Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg [Am] 1999;81-A:2-10. (Pubitemid 29068441)
5. Tanaka N, Sakahashi H, Sato E, et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg [Br] 2001;83-B:702-705. (Pubitemid 32700674)
6. Fahmy NR, Patel DG. Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg [Am] 1981;63-A:461-465. (Pubitemid 11154154)
7. Murphy WG, Davies MJ, Eduardo A. The haemostatic responses to surgery and trauma. Br J Anaesth 1993;70:205-213.
8. Petäjä J, Myllynen P, Myllylä G, Vahtera E. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 1976;153:647-651.
9. Jansen AJ, Andreica S, Claeys M, et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999;83:596-601. (Pubitemid 29458825)
10. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005-1032. (Pubitemid 29313210)
11. Mannucci PM. Hemostatic drugs. N Engl J Med 1998;339:245-253. (Pubitemid 28350168)
12. Prentice CR. Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol) 1980;14:35-40.
13. Kagoma YK, Crowther MA, Douketis J, et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systemic review of randomized trials. Thrombosis Res 2009;123:687-696.
14. Ekbäck G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000;91:1124-1130.
15. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomized, doubleblind study of 86 patients. J Bone Joint Surg [Br] 1996;78-B:434-440. (Pubitemid 26158834)
16. Hiippala S, Strid L, Wennerstrand M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995;74:534-537.
17. Shiga T, Wajima Z, Inoue T, Sakamoto A. Aprotinin in major orthopedic surgery: a systemic review of randomized controlled trials. Anesth Analg 2005;101:1602-1607. (Pubitemid 41720604)
18. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardic surgery. N Engl J Med2006;354:353-365. (Pubitemid 43145060)
19. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement. Acta Chir Belg 2007;107:397-401.
20. Husted H, Blønd L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized doubleblind study in 40 patients. Acta Orthop Scand 2003;74:665-669. (Pubitemid 38067866)
21. Hynes MC, Calder P, Resenfeld P, Scott G. The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study. Ann R Coll Surg Engl 2005;87:99-101. (Pubitemid 40394358)
22. Benoni G, Björkman S, Fredin H. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Invest 1995;10:280-287.
23. Tria AJ Jr, Coon TM. Minimal incision total knee arthroplasty: early experience. Clin Orthop Relat Res 2003;416:185-190. (Pubitemid 37413638)
24. Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978;49:239-243. (Pubitemid 9032534)
25. Haas SB, Cook S, Beksac B. Minimally invasive total knee replacement through a mini midvastus approach: a comparative study. Clin Orthop Relat Res 2004;428:68-73. (Pubitemid 39506153)
26. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-322.
27. Brecher ME, Monk T, Goodnough L. A standard method for calculating blood loss. Transfusion 1997;37:1070-1074. (Pubitemid 27459595)
28. Camarasa MA, Ollé G, Serra-Prat M, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 2006;96:576-582.
29. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg [Br] 2004;86-B:970-973. (Pubitemid 39255858)
30. Wang CJ, Wang JW, Weng LH, et al. Prevention of deep-vein thrombosis after total knee arthroplasty in Asia patients: comparison of low-molecular-weight heparin and indomethacin. J Bone Joint Surg [Am] 2004;86-A:136-140.
31. Pearse EO, Caldwell BF, Lockwood RJ, Hollard J. Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism. J Bone Joint Surg [Br] 2007;80-B:316-322.
32. Well PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997;350:1795-1798. (Pubitemid 28036513)
33. Lin PC, Hsu CH, Chen WS, Wang JW. Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res 2011;469:1995-2002.
34. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg [Am] 2005;87-A:766-770. (Pubitemid 40489352)
35. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003;90:596-599. (Pubitemid 36592332)
36. Arnljots B, Wieslander JB, Dougan P, Salemark L. Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: an experimental study in the rabbit. Microsurgery 1991;12:332-339.
37. Øvrum E, Am Holen E, et al. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg 1993;105:78-83. (Pubitemid 23033763)
38. Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 2000;120:518-520.